Literature DB >> 2044441

Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.

H H Parving1.   

Abstract

Diabetic nephropathy is the main cause of the increased morbidity and mortality in insulin-dependent diabetes mellitus (IDDM) patients. Elevated blood pressure accelerates and effective blood pressure reduction with beta-blockers and/or angiotensin-converting enzyme (ACE) inhibitors delays the progression of nephropathy and reduces albuminuria. All previous reports dealing with the natural history of diabetic nephropathy demonstrated a cumulative death rate between 50 and 77% 10 yr after onset of nephropathy. Effective antihypertensive treatment reduced the cumulative death rate to 15-20% 10 yr after onset of nephropathy. Recent randomized control studies indicate that ACE inhibition may delay and even prevent the development of diabetic nephropathy in normotensive IDDM patients with persistent microalbuminuria. Several cross-sectional and prospective studies suggest an association between elevated blood pressure and the development and progression of diabetic retinopathy. Furthermore, carotid insufficiency or other causes of unilaterally or bilaterally reduced retinal blood flow (pressure) diminish the development of diabetic retinopathy. Diabetic retinopathy is characterized by abnormal leakage of fluorescein through the blood-retinal barrier, an abnormality that can be reversed during antihypertensive treatment. It is well documented that elevated blood pressure, poor metabolic control, and diabetic microangiopathy independently enhance the endothelial leakage of plasma proteins in diabetes mellitus. A link between capillary hypertension, increased extravasation of plasma proteins, and the development and progression of diabetic microangiopathy has been suggested. Blood pressure reduction diminishes the extravasation of plasma proteins. The above results strongly support the case for early and effective treatment of arterial blood pressure elevation in diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044441     DOI: 10.2337/diacare.14.3.260

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

Authors:  K G Dawson; J K McKenzie; S A Ross; J L Chiasson; P Hamet
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

4.  Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition.

Authors:  A A Dosso; E Rungger-Brändle; P M Leuenberger
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

5.  Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Pomerleau; M Verdy; D R Garrel; M H Nadeau
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

Review 6.  Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

Authors: 
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

7.  Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Nørgaard; T Jensen; B Feldt-Rasmussen
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

8.  The prevalence of microalbuminuria and associated risk factors in a population with insulin-dependent diabetes mellitus.

Authors:  T M Fiad; R Freaney; B Murray; M J McKenna
Journal:  Ir J Med Sci       Date:  1993-08       Impact factor: 1.568

9.  Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy.

Authors:  J A Pugh; R Medina; M Ramirez
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

10.  Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients.

Authors:  C E Kullberg; H J Arnqvist
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.